Precigen Inc. (PGEN) PT Raised to $15 at Stifel; 'Topline Data On AG019 ActoBiotics Look Encouraging'
Tweet Send to a Friend
Stifel analyst Benjamin Burnett raised the price target on Precigen Inc. (NASDAQ: PGEN) to $15.00 (from $14.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
